Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
August 30, 2001

LORAZEPAM Tablets Recalled

Toledo, OH  (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Heartland Repack Services,  is recalling LORAZEPAM Tablets, USP, 0.5mg, NDC #61392-455-39, packaged as 30 tablets per 'bingo' card, 140 cards per case.

This is the first public notice of this Class II recall issued by the FDA.

RECALL NUMBER, PRODUCT AND CODE:
D-291-1, LORAZEPAM Tablets, USP, 0.5mg, NDC #61392-455-39, packaged as 30 tablets per 'bingo' card, 140 cards per case.

Code:
Lot Number: 18291 Exp Date: 5/31/2003

REASON:
CONTAINER DEFECT; The plastic material used to repackage the individual tablets is de-laminating.

MANUFACTURER/RECALLING FIRM:
Geneva Pharmaceuticals, Broomfield, CO

RECALLED BY:
Heartland Repack Services, Toledo, OH, on 8/3/2001, by letter.

FIRM INITIATED RECALL:
Ongoing

DISTRIBUTION:
Nationwide

QUANTITY:
10,588 cards

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.